AZTA
Price
$27.11
Change
+$1.31 (+5.08%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
3.36B
17 days until earnings call
RSLS
Price
$0.38
Change
-$0.01 (-2.56%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
4.33M
Ad is loading...

AZTA vs RSLS

Header iconAZTA vs RSLS Comparison
Open Charts AZTA vs RSLSBanner chart's image
Azenta
Price$27.11
Change+$1.31 (+5.08%)
Volume$4.03K
Capitalization3.36B
ReShape Lifesciences
Price$0.38
Change-$0.01 (-2.56%)
Volume$6.65K
Capitalization4.33M
AZTA vs RSLS Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. RSLS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and RSLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AZTA: $25.79 vs. RSLS: $0.39)
Brand notoriety: AZTA and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 101% vs. RSLS: 16%
Market capitalization -- AZTA: $3.36B vs. RSLS: $4.33M
AZTA [@Medical Specialties] is valued at $3.36B. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileRSLS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • RSLS’s FA Score: 1 green, 4 red.
According to our system of comparison, both AZTA and RSLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while RSLS’s TA Score has 2 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 2 bearish.
  • RSLS’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than RSLS.

Price Growth

AZTA (@Medical Specialties) experienced а +1.14% price change this week, while RSLS (@Medical Specialties) price change was +6.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

AZTA is expected to report earnings on Jul 31, 2025.

RSLS is expected to report earnings on Apr 04, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than RSLS($4.33M). AZTA YTD gains are higher at: -48.420 vs. RSLS (-91.480). AZTA has higher annual earnings (EBITDA): 57.5M vs. RSLS (-36.72M). AZTA has more cash in the bank: 984M vs. RSLS (1.45M). RSLS has less debt than AZTA: RSLS (285K) vs AZTA (66.5M). AZTA has higher revenues than RSLS: AZTA (641M) vs RSLS (9.81M).
AZTARSLSAZTA / RSLS
Capitalization3.36B4.33M77,734%
EBITDA57.5M-36.72M-157%
Gain YTD-48.420-91.48053%
P/E RatioN/AN/A-
Revenue641M9.81M6,537%
Total Cash984M1.45M67,909%
Total Debt66.5M285K23,333%
FUNDAMENTALS RATINGS
AZTA vs RSLS: Fundamental Ratings
AZTA
RSLS
OUTLOOK RATING
1..100
5988
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9198
PRICE GROWTH RATING
1..100
9498
P/E GROWTH RATING
1..100
47100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSLS's Valuation (28) in the Medical Specialties industry is somewhat better than the same rating for AZTA (77) in the Electronic Production Equipment industry. This means that RSLS’s stock grew somewhat faster than AZTA’s over the last 12 months.

RSLS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that RSLS’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's SMR Rating (91) in the Electronic Production Equipment industry is in the same range as RSLS (98) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to RSLS’s over the last 12 months.

AZTA's Price Growth Rating (94) in the Electronic Production Equipment industry is in the same range as RSLS (98) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to RSLS’s over the last 12 months.

AZTA's P/E Growth Rating (47) in the Electronic Production Equipment industry is somewhat better than the same rating for RSLS (100) in the Medical Specialties industry. This means that AZTA’s stock grew somewhat faster than RSLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTARSLS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRWRX20.01N/A
N/A
MFS Blended Research Growth Eq R1
GGIAX13.18N/A
N/A
Goldman Sachs Global Infras A
CLGPX14.23N/A
N/A
Columbia Large Cap Growth Opp R
WSHCX57.30N/A
N/A
American Funds Washington Mutual C
PRGTX17.33N/A
N/A
T. Rowe Price Global Technology

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.95%
IQV - AZTA
61%
Loosely correlated
+2.40%
TMO - AZTA
60%
Loosely correlated
-0.71%
RVTY - AZTA
59%
Loosely correlated
+1.46%
A - AZTA
55%
Loosely correlated
+2.13%
CRL - AZTA
54%
Loosely correlated
+1.97%
More

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with BIAF. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then BIAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
-2.56%
BIAF - RSLS
53%
Loosely correlated
+3.50%
HSCS - RSLS
35%
Loosely correlated
-3.26%
GMED - RSLS
31%
Poorly correlated
+1.78%
AZTA - RSLS
30%
Poorly correlated
+5.16%
LFWD - RSLS
29%
Poorly correlated
-0.68%
More